DEGROOF PETERCAM Maintains VGP (VGPBF) Buy Recommendation

DeGroof Petercam maintained a Buy on VGP (OTCPK:VGPBF) on Dec. 15, 2025, but as of Jan. 29, 2025 the average one‑year analyst price target was $101 (range $68.08–$140.43), implying about 13.7% downside from the then closing price of $116.99. Management/projections point to revenue of $184M (+11.7%) and non‑GAAP EPS of 5.81, while institutional interest has ticked up modestly—84 funds hold the stock (up 1.2%), total institutional shares rose 6.8% to ~1.219M and major passive managers (Vanguard, iShares) marginally increased allocations—indicating steady investor demand despite mixed signals on near‑term valuation.

Analysis

DeGroof Petercam maintained a Buy on VGP (OTCPK:VGPBF) on December 15, 2025, while the reported consensus one‑year analyst price target as of January 29, 2025 is $101.00 (range $68.08–$140.43), which implies a 13.67% downside versus the latest closing price of $116.99 and highlights a clear disconnect between the Buy rating and average market expectations. Projected company fundamentals in the report show annual revenue of $184 million (up 11.73%) and projected non‑GAAP EPS of 5.81, providing a constructive earnings/revenue backdrop that may support valuation if realized. Institutional positioning is moderately positive: 84 funds hold the stock (up 1.2% quarter over quarter), total institutional shares rose 6.78% to ~1.219 million, and several large passive vehicles (Vanguard and iShares funds) incrementally increased allocations, although average portfolio weight remains small at 0.15% (up 10.54%). The wide analyst target range and the mixed sentiment score (−0.1; label: mixed, market impact 0.25) indicate meaningful valuation dispersion and limited market conviction, so near‑term price action will likely hinge on execution against the projected revenue and EPS figures and any forthcoming analyst revisions.

Key Decisions for Investors

• Given the consensus one‑year target implies ~13.7% downside despite a Buy from DeGroof Petercam, consider reducing or hedging exposure to limit downside risk
• Monitor upcoming results versus the projected $184M revenue and non‑GAAP EPS 5.81 and treat confirmed beats as a catalyst to add, misses as a trigger to reassess positioning
• Watch analyst target revisions and the wide $68–$140.43 range for changes in conviction, and track continued incremental buying by passive/institutional holders as a potential liquidity/support signal
• If initiating a new position, prefer to wait for price convergence toward the $101 consensus target or for clear confirmation of the projected fundamentals before adding materially